文献速递心脑血管急症重症综合管理与镇静镇痛

重症动脉瘤性蛛网膜下腔出血患者的钠代谢紊乱与6个月功能预后:一项前瞻性队列研究

Dysnatremia and 6-Month Functional Outcomes in Critically Ill Patients With Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study.
PubMed 文献 · Crit Care Explor · 2021-06-08
一句话结论重症aSAH患者中,较高的平均血钠水平和更大的血钠变异性与6个月不良神经预后独立相关,但需干预性研究证实因果。

多变量分析显示,较高的平均钠浓度(OR 1.17,95%CI 1.05-1.29)和较大的钠变异性(OR 1.53,95%CI 1.17-1.99)与不良预后相关;钠变异性还与更长的ICU和住院时间相关。该研究提示血钠管理可能影响aSAH患者预后,但需干预性研究验证因果关系。

要点

  • 血钠变异性(以标准差衡量)越大,6个月不良预后风险越高(OR 1.53,95%CI 1.17-1.99)。
  • 初始高血钠后从第3天起逐渐下降的模式也与不良预后相关。
  • 血钠变异性增大还与更长的ICU住院时间(比值1.13,95%CI 1.07-1.20)和总住院时间(比值1.08,95%CI 1.01-1.15)相关。
  • 该研究为观察性关联,不能证明因果关系,需干预性研究验证。

适用人群与场景

  • 排除标准原文未提及。

诊断标准与关键阈值

  • 不良预后定义为6个月改良Rankin量表评分≥4。
  • 暴露变量为每日测量的血浆钠浓度。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 主要终点:6个月改良Rankin量表评分≥4;多变量分析(校正年龄、病情严重程度和医疗过程指标)显示,较高的平均钠浓度(OR 1.17,95%CI 1.05-1.29)和较大的钠变异性(OR 1.53,95%CI 1.17-1.99)与不良预后相关。
  • 广义相加模型显示,初始高血钠后从第3天起逐渐下降的模式也与不良预后相关。
  • 钠变异性增大与更长的ICU住院时间(比值1.13,95%CI 1.07-1.20)和住院时间(比值1.08,95%CI 1.01-1.15)相关。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究;证据等级或推荐强度原文未提及。
  • 局限:观察性设计不能证明因果关系;原文未提及其他局限。

对床旁实践的改变

  • 该研究提示在重症aSAH患者中,较高的平均血钠水平和较大的血钠变异性与6个月不良神经预后相关,可能支持在床旁更关注血钠水平和变异性,但原文未给出具体干预阈值或措施。
  • 原文未提及适用与不适用人群的进一步区分。
  • 常见陷阱:不能将观察性关联误认为因果,原文明确指出需干预性研究证实因果关系。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the association between plasma sodium concentrations and 6-month neurologic outcome in critically ill patients with aneurysmal subarachnoid hemorrhage.

DESIGN: Prospective cohort study.

SETTING: Eleven ICUs in Australia and New Zealand.

PARTICIPANTS: Three-hundred fifty-six aneurysmal subarachnoid hemorrhage patients admitted to ICU between March 2016 and June 2018. The exposure variable was daily measured plasma sodium.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Six-month neurologic outcome as measured by the modified Rankin Scale. A poor outcome was defined as a modified Rankin Scale greater than or equal to 4. The mean age was 57 years (± 12.6 yr), 68% were female, and 32% (n = 113) had a poor outcome. In multivariable analysis, including age, illness severity, and process of care measures as covariates, higher mean sodium concentrations (odds ratio, 1.17; 95% CI, 1.05-1.29), and greater overall variability-as measured by the sd (odds ratio, 1.53; 95% CI, 1.17-1.99)-were associated with a greater likelihood of a poor outcome. Multivariable generalized additive modeling demonstrated, specifically, that a high initial sodium concentration, followed by a gradual decline from day 3 onwards, was also associated with a poor outcome. Finally, greater variability in sodium concentrations was associated with a longer ICU and hospital length of stay: mean ICU length of stay ratio (1.13; 95% CI, 1.07-1.20) and mean hospital length of stay ratio (1.08; 95% CI, 1.01-1.15).

CONCLUSIONS: In critically ill aneurysmal subarachnoid hemorrhage patients, higher mean sodium concentrations and greater variability were associated with worse neurologic outcomes at 6 months, despite adjustment for known confounders. Interventional studies would be required to demonstrate a causal relationship.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Cohen J, Delaney A, Anstey J, et al. Dysnatremia and 6-Month Functional Outcomes in Critically Ill Patients With Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study. Crit Care Explor. 2021. PMID: 34124687. doi:10.1097/CCE.0000000000000445

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。